[269 pages Report] FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.5 Bn in 2022. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 6.2% CAGR through 2030. The report opines that AI's growing penetration in the healthcare sector will also rub off on contrast media injectors industry during the next decade.

Data Points

Market Insights

Market Value 2021

USD 1.4 Bn

Market Value 2022

USD 1.5 Bn

Market Value 2030

USD 2.4 Bn

CAGR 2022-2030

6.2%

Key Players

The key players are Bayer AG, Nemoto Kyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG,

Share of Top 5 Countries

58.1%

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-823

Key Takeaways of Contrast Media Injectors Market Study

• North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2022 and this trend is expected to continue during the forecast period
• Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
• AI is expected to speed up the process of injecting contrast media in the forecast period
• Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

"Development of advanced contrast media injectors including automated and IT/software technology at low cost is the major focus area of the manufacturers, which provides a competitive advantage" says an FMI Analyst.

Ask from Market Research Expert - https://www.futuremarketinsights.com/ask-question/rep-gb-823

New Product Launches and Approval - The Ongoing Trend

The market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

• In Apr 2022, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.
• In Nov 2021, the US FDA approved an MRI contrast agent "Clariscan" for intravenous use in spine, brain (intracranial), and associated tissues.
• In Aug 2021, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

What else is in the report?

Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2014 - 2021 and projections from 2022-2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

Contrast Media Injectors Market by Category

By Product:

• CT Injectors
• MRI Injectors
• Cardio Injectors

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/823

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Diagnostics Centers

More Trending Reports by Future Market Research :

Dehydrated Culture Media Market : According to the latest research by Future Market Insights, Dehydrated Culture Media market is expected to grow at a CAGR of 7.7% during the forecast period.

Contrast Injection Lines Market : The global contrast injection lines market size is likely to be valued at US$ 5.1 Billion in 2022 and exhibit growth at a CAGR of 4.7% in the forecast period from 2022 to 2032.

Magnetic Resonance Imaging (MRI) Contrast Agents Market : The global Magnetic Resonance Imaging (MRI) Contrast Agents Market recorded sales worth U.S. $ 871.0 Mn in the year 2021.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights,

Unit No: 1602-006,

Jumeirah Bay 2,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers,

Dubai,

United Arab Emirates

For Sales Enquiries: [email protected]

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

The post Contrast Media Injectors Market is expected to reach US$ 2.4 Bn by 2030 with sales revenue expected to register CAGR of 6.2% from 2022 - 2030 appeared first on Future Market Insights.

Original Source of the original story >> Contrast Media Injectors Market is expected to reach US$ 2.4 Bn by 2030 with sales revenue expected to register CAGR of 6.2% from 2022 - 2030

This content is published on behalf of the above source. Please contact them directly for any concern related to the above.

This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.